These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38560509)

  • 21. Severe neuroleptic malignant syndrome: successful treatment with high-dose lorazepam and diazepam: a case report.
    Tsai MC; Huang TL
    Chang Gung Med J; 2010; 33(5):576-80. PubMed ID: 20979709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroleptic malignant syndrome secondary to quetiapine.
    Gortney JS; Fagan A; Kissack JC
    Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A fatal case of fulminant neuroleptic malignant syndrome: A case report.
    Komoriya H; Nomura K; Shirata T; Kobayashi T; Nakane M; Noto K; Kobayashi R; Suzuki A
    PCN Rep; 2023 Mar; 2(1):e75. PubMed ID: 38868402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful management of delirium with dexmedetomidine in a patient with haloperidol-induced neuroleptic malignant syndrome: A case report.
    Yang CJ; Chiu CT; Yeh YC; Chao A
    World J Clin Cases; 2022 Jan; 10(2):625-630. PubMed ID: 35097088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic malignant syndrome with abnormally elevated cardiac troponin I: a case report.
    Wang Q; Shi J; Zhao P; Cao Q; Yao Z
    J Int Med Res; 2020 Nov; 48(11):300060520968344. PubMed ID: 33203271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic malignant syndrome associated with atypical antipsychotics: A case report.
    Mogollon Díaz JP; Lizcano Toloza LY; Serrano García AY; Alquichire Luna CA; García Bohorquez DF; Chaparro Durán MF; Cáceres Valero MV
    Rev Colomb Psiquiatr (Engl Ed); 2023; 52(1):78-81. PubMed ID: 37031016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Malignant neuroleptic syndrome after haloperidol administration].
    Gerbershagen MU; Ito WD; Wappler F; Fiege M; Schulte am Esch J
    Anaesthesist; 2001 May; 50(5):329-32. PubMed ID: 11417268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroleptic malignant syndrome associated with metoclopramide in a child.
    Yaman A; Kendirli T; Ödek Ç; Yıldız C; Beğde F; Erkol H; İnce E
    Turk J Pediatr; 2014; 56(5):535-7. PubMed ID: 26022591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptic malignant syndrome in a patient with tongue cancer: a report of a rare case.
    Baba O; Yamagata K; Tomidokoro Y; Tamaoka A; Itoh H; Yanagawa T; Onizawa K; Bukawa H
    Case Rep Dent; 2013; 2013():542130. PubMed ID: 23853728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic dose escalation as a trigger for neuroleptic malignant syndrome (NMS): literature review and case series report.
    Langan J; Martin D; Shajahan P; Smith DJ
    BMC Psychiatry; 2012 Nov; 12():214. PubMed ID: 23194104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
    Reeves RR; Mack JE; Torres RA
    Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroleptic malignant syndrome in a patient treated with lithium carbonate and haloperidol.
    Yang Y; Guo Y; Zhang A
    Shanghai Arch Psychiatry; 2014 Dec; 26(6):368-70. PubMed ID: 25642114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroleptic Malignant Syndrome: A Potential Etiology of Multisystem Organ Failure in a Burn Patient.
    Ficarino HM; Caposole MZ; Noelle Davis S; N Krebsbach M; McGowin EF; Alexander KM; Kinnard CM; Simmons JD
    Am Surg; 2022 Mar; 88(3):519-520. PubMed ID: 32988244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotics: A Case Report.
    Mogollon Díaz JP; Lizcano Toloza LY; Serrano García AY; Alquichire Luna CA; García Bohorquez DF; Chaparro Durán MF; Cáceres Valero MV
    Rev Colomb Psiquiatr (Engl Ed); 2021 Jul; ():. PubMed ID: 34243899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haloperidol-Induced Neuroleptic Malignant Syndrome: A Case Report.
    Fader JP; Walker Evans M; Lundgren AM; Sigmund TB; Allen TJ
    Cureus; 2024 Mar; 16(3):e57276. PubMed ID: 38686249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical neuroleptic malignant syndrome in an incarcerated patient: a demographic who may be at increased risk.
    Zabel M; Kandukuri R
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38320820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of an animal model for neuroleptic malignant syndrome: heat-exposed rabbits with haloperidol and atropine administration exhibit increased muscle activity, hyperthermia, and high serum creatine phosphokinase level.
    Tanii H; Taniguchi N; Niigawa H; Hosono T; Ikura Y; Sakamoto S; Kudo T; Nishimura T; Takeda M
    Brain Res; 1996 Dec; 743(1-2):263-70. PubMed ID: 9017254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic malignant syndrome in patients with COVID-19.
    Soh M; Hifumi T; Isokawa S; Shimizu M; Otani N; Ishimatsu S
    Am J Emerg Med; 2020 Oct; 38(10):2243.e1-2243.e3. PubMed ID: 32473756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic malignant syndrome: a case report.
    Fekadu A; Wakwoya A
    Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.